UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005769
Receipt number R000006818
Scientific Title Usefulness of sitagliptin for type 2 diabetes pacients
Date of disclosure of the study information 2011/06/13
Last modified on 2011/06/13 15:54:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Usefulness of sitagliptin for type 2 diabetes pacients

Acronym

Usefulness of sitagliptin for type 2 diabetes pacients

Scientific Title

Usefulness of sitagliptin for type 2 diabetes pacients

Scientific Title:Acronym

Usefulness of sitagliptin for type 2 diabetes pacients

Region

Japan


Condition

Condition

type 2 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare
1) Achievement rate for glycemic control target,
2) Influence against risk marker for complication of diabetes
3) Influence against an islet of Langerhans function in pancreas
under treatment by sitagliptin in type 2 diabetes patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Achievement rate for glycemic control target

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Sitagliptin

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

type2 diabetes whose HbA1c is 6.5 <= , 20 years-old <=

Key exclusion criteria

1)diabetic ketosis, lethargic sleep
2)infection , past history of abdominal operation, past history of ileus, serious injury
3)pregnancy or suspicious pregnancy, lactation
4)renal failure
5)insulin in use

Target sample size

300


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazunori Utsunomiya

Organization

Jikei University School of Medicine

Division name

Division of Diabetes, Metabolism and Endocrinology Department of Internal Medicine

Zip code


Address

3-25-8 Nishishimbashi, Minato-ku, Tokyo 105-8461 Japan

TEL

03-3433-1111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Tamotsu Yokota

Organization

Jikei University School of Medicine

Division name

Division of Diabetes, Metabolism and Endocrinology Department of Internal Medicine

Zip code


Address

3-25-8 Nishishimbashi, Minato-ku, Tokyo

TEL

03-3433-1111

Homepage URL


Email



Sponsor or person

Institute

Jikei University School of Medicine, Division of Diabetes, Metabolism and Endocrinology Department of Internal Medicine

Institute

Department

Personal name



Funding Source

Organization

Japan Diabetes Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor

NTT Medical Center Tokyo, Showa University,
Toshiba General Hospital, Toho University Omori Medical center, TOHO University Ohashi Medical center, Toranomon Hospital

Name of secondary funder(s)

No


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 06 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2011 Year 02 Month 10 Day

Date of IRB


Anticipated trial start date

2011 Year 06 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 06 Month 13 Day

Last modified on

2011 Year 06 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006818


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name